In this study, combined with the bioinformatics analysis and research of predecessors, it was speculated that LBX2-AS1 modulated the expression of FSTL3 by recruiting RARα to hasten the progression of thyroid cancer. This evidence concerns the gene LBX2 and thyroid gland carcinoma.